About this trial
The project explores the use of virtual reality (VR) as a tool to improve the quality of life of people with dependence, providing immersive and personalized environments that support physical, neurological and psychological rehabilitation. VR makes it possible to practice complex movements, improve strength and coordination, reduce stress and anxiety, and enhance brain plasticity through adapted simulations that are also motivating and safe for users. This approach facilitates more effective rehabilitation than traditional therapies by allowing repetition and visualization of movements that are difficult to perform in real life. The El Saliente Association, in collaboration with the University of Almeria, leads this initiative that seeks to promote the autonomy, inclusion and emotional well-being of people with dependence. With specific objectives such as improving motor function, stimulating neuroplasticity, reducing pain through immersive distraction and enhancing independence, the project uses VR sessions in controlled environments. In addition, activities that simulate everyday situations will be designed to facilitate the transfer of acquired skills to the real environment. The work plan is divided into design, development, implementation and analysis phases, including participant selection, software development, pilot testing and evaluation of results. At each stage, data will be collected to measure the effectiveness of the intervention, with the ultimate goal of publishing the findings in scientific forums and replicating the experience in other contexts. Day center facilities and a residential complex will provide the necessary spaces and materials to carry out the interventions. Expected outcomes include increased motivation and adherence to therapy, faster functional recovery and an overall improvement in quality of life, including increased self-esteem and reduced anxiety. This project promises a significant advance in the use of technology for inclusive rehabilitation, with benefits not only for patients but also for the advancement of innovative therapeutic solutions in the field of dependency.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Over 18 years of age
Patients who agree to participate in the study and sign the informed consent form.
Disqualifiers
Those with severe visual impairment, vertigo, epilepsy or psychosis, and who may interfere with the normal performance of interactive voice response (IVR) tasks, will be excluded as a precaution.
Trial design
Parallel
Treatments tested in this trial
Immersive Virtual Reality with Head Mounted Display
DeviceThe intervention will be carried out with an immersive virtual reality device, specifically, with a head mounted display. Specifically, it is the "MetaQuest 3" model.
Aerobic exercise and strength training
Other interventionThe combination of aerobic and strength training is part of the conventional physiotherapy treatment carried out at the center.
Treatment groups
Trial outcomes
Primary outcomes
Anxiety levels
Anxiety levels will be measured using the Generalized Anxiety Disorder (GAD-7).
Secondary outcomes
Adherence levels
The level of adherence to the intervention will be measured by keeping a record of users who do or do not complete the sessions, in order to establish the dropout rate.
Functional mobility
Functional mobility will include the evaluation of gait and balance using the Tinetti scale (0-28 points).
Ability to perform activities of daily living
The ability to perform activities of daily living will be measured using the Barthel Index (0-100 points).
Cognitive impairment
Cognitive impairment will be measured using the Lobo Mini Cognitive Test.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.